Linda Chen

发表

Evaluation of Substantial Reduction in Elective Radiotherapy Dose and Field in Patients With Human Papillomavirus-Associated Oropharyngeal Carcinoma Treated With Definitive Chemoradiotherapy.

N. Lee, R. Wong, N. Riaz, 2022, JAMA oncology.

Platinum‐based regimens versus cetuximab in definitive chemoradiation for human papillomavirus‐unrelated head and neck cancer

N. Lee, D. Pfister, N. Riaz, 2020, International journal of cancer.

Any day, split halfway: Flexibility in scheduling high‐dose cisplatin—A large retrospective review from a high‐volume cancer center

N. Lee, I. Ganly, Bhuvanesh Singh, 2021, International journal of cancer.

Peer Review of Head and Neck Cancer Planning Target Volumes in Radiation Oncology

N. Riaz, S. McBride, D. Gelblum, 2022, Advances in radiation oncology.

Last-line local treatment with the Quad Shot regimen for previously irradiated head and neck cancers.

N. Lee, I. Ganly, Bhuvanesh Singh, 2020, Oral oncology.

Consensuses, controversies, and future directions in treatment deintensification for human papillomavirus‐associated oropharyngeal cancer

N. Lee, I. Ganly, Bhuvanesh Singh, 2022, CA: a cancer journal for clinicians.

Temporal Lobe Necrosis in Head and Neck Cancer Patients after Proton Therapy to the Skull Base

C. Brennan, N. Lee, I. Ganly, 2020, International journal of particle therapy.

Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Oropharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy

N. Lee, I. Ganly, Bhuvanesh Singh, 2022, JAMA network open.

Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Nasopharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy

N. Lee, N. Riaz, D. Mah, 2021, JAMA network open.

TERT Promoter Mutations Are Enriched in Oral Cavity Cancers and Associated With Locoregional Recurrence

S. Dogan, N. Lee, N. Katabi, 2021, JCO precision oncology.

Nongaussian Intravoxel Incoherent Motion Diffusion Weighted and Fast Exchange Regime Dynamic Contrast-Enhanced-MRI of Nasopharyngeal Carcinoma: Preliminary Study for Predicting Locoregional Failure

N. Lee, A. Shukla-Dave, V. Hatzoglou, 2021, Cancers.

Timing of surgery and adjuvant radiation therapy for sinonasal malignancies: Effect of surgical approach

Qasim Husain, N. Lee, I. Ganly, 2019, Head & neck.

Current considerations for radiotherapy in HPV‐associated head and neck cancer

N. Lee, N. Riaz, S. McBride, 2021, Journal of surgical oncology.

The 3 Bs of cancer care amid the COVID‐19 pandemic crisis: “Be safe, be smart, be kind”—A multidisciplinary approach increasing the use of radiation and embracing telemedicine for head and neck cancer

J. Shah, N. Lee, I. Ganly, 2020, Cancer.

Outcomes and prognostic factors of major salivary gland tumors treated with proton beam radiation therapy

N. Lee, R. Wong, N. Riaz, 2021, Head & neck.

Post-operative PET/CT improves the detection of early recurrence of squamous cell carcinomas of the oral cavity.

N. Lee, I. Ganly, Bhuvanesh Singh, 2023, Oral oncology.

The effect of short radiation treatment breaks on chemo‐radiotherapy for oropharyngeal cancers

N. Lee, R. Wong, N. Riaz, 2021, Head & neck.

Stem cell-like T cell depletion in the recurrent head and neck cancer immune microenvironment

J. Reis-Filho, N. Lee, N. Katabi, 2023, Oncoimmunology.

Concurrent carboplatin and paclitaxel definitive radiation therapy for locally advanced head and neck cancer

N. Lee, R. Wong, N. Riaz, 2023, Head & neck.

Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 study

J. Reis-Filho, N. Riaz, D. Higginson, 2023, The Lancet.